# SLC2A2

## Overview
The SLC2A2 gene encodes the protein solute carrier family 2 member 2, commonly known as GLUT2, which is a member of the major facilitator superfamily of membrane transporters. GLUT2 is a transmembrane protein that plays a pivotal role in glucose homeostasis by facilitating the transport of glucose and other substrates across cell membranes. It is characterized by its 12 transmembrane helices, which form a channel allowing for the passive movement of glucose down concentration gradients (Holman2020Structure). GLUT2 is primarily expressed in the liver, pancreatic β cells, the intestine, and the kidney, where it is integral to processes such as glucose uptake, reabsorption, and insulin secretion (Mueckler2013The). The protein's function is crucial for maintaining metabolic balance, and mutations in the SLC2A2 gene are associated with metabolic disorders such as Fanconi-Bickel syndrome and neonatal diabetes (Sansbury2012SLC2A2; Grünert2021Evidence).

## Structure
The SLC2A2 gene encodes the GLUT2 protein, a member of the major facilitator superfamily of membrane transporters. GLUT2 is characterized by its structure, which includes 12 transmembrane helices forming a channel that facilitates the transport of glucose and other substrates across cell membranes (Holman2020Structure). The protein's structure is built from a replicated trimer substructure, which is a common feature among GLUT proteins, allowing for the passive movement of glucose down concentration gradients (Holman2020Structure).

GLUT2 has a relatively high affinity for glucose and fructose, with specific binding kinetics that are crucial for its function in glucose homeostasis (Holman2020Structure). The protein is primarily expressed in the liver, pancreatic β cells, the intestine, and the kidney, where it plays a significant role in glucose uptake and reabsorption (Mueckler2013The).

While specific details on the primary, secondary, tertiary, and quaternary structures of GLUT2 are not provided, the general structural features of GLUT proteins, such as the alternating access model and the presence of conserved salt bridging motifs, are relevant to its function (Holman2020Structure). The availability of GLUT crystal structures has advanced the understanding of their function and facilitated the search for specific inhibitors and substrates for therapeutic use (Holman2020Structure).

## Function
The SLC2A2 gene encodes the GLUT2 protein, a glucose transporter with a low affinity for glucose, which allows it to function effectively in various tissues under physiological conditions. In the liver, GLUT2 is crucial for bi-directional glucose transport, facilitating glucose uptake in the fed state and release during fasting, thus maintaining glucose homeostasis (Mueckler2013The; Sun2023The). In pancreatic beta cells, GLUT2 plays a permissive role in glucose-stimulated insulin secretion by allowing glucose entry, which triggers the insulin secretion pathway (Sun2023The). 

In the kidneys, GLUT2 is essential for glucose reabsorption in the proximal tubule cells, working alongside SGLT2 to prevent glucose loss in urine (Ahmad2022Kidney). In the intestine, GLUT2 facilitates glucose absorption by transporting glucose from enterocytes to the blood, particularly after meals when glucose levels rise (Sun2023The). 

GLUT2 is also expressed in the central nervous system, where it is involved in glucose sensing, influencing feeding behavior, energy expenditure, and thermogenesis (Thorens2014GLUT2). Its role in glucose sensing and homeostasis is crucial for maintaining metabolic balance in healthy human cells (Sun2023The).

## Clinical Significance
Mutations in the SLC2A2 gene, which encodes the glucose transporter protein GLUT2, are associated with several metabolic disorders. One of the primary conditions linked to SLC2A2 mutations is Fanconi-Bickel syndrome (FBS), a rare autosomal recessive disorder characterized by hepatic glycogen storage disease, proximal renal tubular dysfunction, and impaired galactose tolerance (Sharari2020Fanconi–Bickel; Grünert2021Evidence). Patients with FBS often present with symptoms such as hepatomegaly, growth retardation, and renal Fanconi syndrome (Thorens2014GLUT2).

SLC2A2 mutations can also lead to neonatal diabetes, either as permanent neonatal diabetes mellitus (PNDM) or transient neonatal diabetes mellitus (TNDM). These conditions are characterized by early-onset diabetes, often accompanied by low birth weight and insulin deficiency (Sansbury2012SLC2A2). The exact mechanism by which SLC2A2 mutations cause neonatal diabetes is not fully understood, but it is suggested that impaired GLUT2 function affects insulin secretion (Sansbury2012SLC2A2).

In addition to these conditions, alterations in GLUT2 expression or function have been implicated in dysglycemia, including fasting hypoglycemia and postprandial hyperglycemia, due to its role in glucose homeostasis (Sharari2020Fanconi–Bickel). Variants in GLUT2 have also been associated with an increased risk of type 2 diabetes and cardiovascular diseases (Thorens2014GLUT2).

## Interactions
The SLC2A2 gene encodes the glucose transporter protein GLUT2, which is involved in several critical interactions with other proteins. In pancreatic beta cells, GLUT2 facilitates glucose uptake, which is essential for glucose-stimulated insulin secretion (GSIS). This process involves interactions with glucokinase, allowing glucose access and subsequent insulin release (Thorens2014GLUT2). GLUT2 also interacts with galectin-9, a lectin that anchors it at the cell surface, and this interaction is crucial for maintaining GSIS. Disruption of this interaction can affect insulin secretion (Thorens2014GLUT2).

In the liver, GLUT2 is involved in glucose sensing and metabolism, interacting with glucose-6-phosphatase (G6PC) to facilitate glucose production through gluconeogenesis and glycogenolysis. This interaction is vital for blood glucose regulation (Sneha2018Probing). GLUT2 also plays a role in the hepatoportal glucose sensor mechanism, influencing glucagon secretion and glucose uptake (Thorens2014GLUT2).

GLUT2's interactions extend to the nervous system, where it is involved in glucose sensing and autonomic regulation, affecting both parasympathetic and sympathetic nerve activities. This includes interactions with neurons in the nucleus tractus solitarius, which are activated by hypoglycemia to regulate glucagon secretion (Thorens2014GLUT2).


## References


[1. (Thorens2014GLUT2) Bernard Thorens. Glut2, glucose sensing and glucose homeostasis. Diabetologia, 58(2):221–232, November 2014. URL: http://dx.doi.org/10.1007/s00125-014-3451-1, doi:10.1007/s00125-014-3451-1. This article has 510 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-014-3451-1)

[2. (Mueckler2013The) Mike Mueckler and Bernard Thorens. The slc2 (glut) family of membrane transporters. Molecular Aspects of Medicine, 34(2–3):121–138, April 2013. URL: http://dx.doi.org/10.1016/j.mam.2012.07.001, doi:10.1016/j.mam.2012.07.001. This article has 952 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.mam.2012.07.001)

[3. (Sharari2020Fanconi–Bickel) Sanaa Sharari, Mohamad Abou-Alloul, Khalid Hussain, and Faiyaz Ahmad Khan. Fanconi–bickel syndrome: a review of the mechanisms that lead to dysglycaemia. International Journal of Molecular Sciences, 21(17):6286, August 2020. URL: http://dx.doi.org/10.3390/ijms21176286, doi:10.3390/ijms21176286. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21176286)

[4. (Sansbury2012SLC2A2) F. H. Sansbury, S. E. Flanagan, J. A. L. Houghton, F. L. Shuixian Shen, A. M. S. Al-Senani, A. M. Habeb, M. Abdullah, A. Kariminejad, S. Ellard, and A. T. Hattersley. Slc2a2 mutations can cause neonatal diabetes, suggesting glut2 may have a role in human insulin secretion. Diabetologia, 55(9):2381–2385, June 2012. URL: http://dx.doi.org/10.1007/s00125-012-2595-0, doi:10.1007/s00125-012-2595-0. This article has 111 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-012-2595-0)

[5. (Sun2023The) Bo Sun, Hui Chen, Jisu Xue, Peiwu Li, and Xu Fu. The role of glut2 in glucose metabolism in multiple organs and tissues. Molecular Biology Reports, 50(8):6963–6974, June 2023. URL: http://dx.doi.org/10.1007/s11033-023-08535-w, doi:10.1007/s11033-023-08535-w. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11033-023-08535-w)

[6. (Sneha2018Probing) P. Sneha, D. Thirumal Kumar, Jose Lijo, M. Megha, R. Siva, and C. George Priya Doss. Probing the Protein–Protein Interaction Network of Proteins Causing Maturity Onset Diabetes of the Young, pages 167–202. Elsevier, 2018. URL: http://dx.doi.org/10.1016/bs.apcsb.2017.07.004, doi:10.1016/bs.apcsb.2017.07.004. This article has 14 citations.](https://doi.org/10.1016/bs.apcsb.2017.07.004)

[7. (Holman2020Structure) Geoffrey D. Holman. Structure, function and regulation of mammalian glucose transporters of the slc2 family. Pflügers Archiv - European Journal of Physiology, 472(9):1155–1175, June 2020. URL: http://dx.doi.org/10.1007/s00424-020-02411-3, doi:10.1007/s00424-020-02411-3. This article has 120 citations.](https://doi.org/10.1007/s00424-020-02411-3)

[8. (Ahmad2022Kidney) Majdoleen Ahmad, Ifat Abramovich, Bella Agranovich, Alina Nemirovski, Eyal Gottlieb, Liad Hinden, and Joseph Tam. Kidney proximal tubule glut2—more than meets the eye. Cells, 12(1):94, December 2022. URL: http://dx.doi.org/10.3390/cells12010094, doi:10.3390/cells12010094. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12010094)

[9. (Grünert2021Evidence) Sarah C. Grünert, Anke Schumann, Federico Baronio, Konstantinos Tsiakas, Simona Murko, Ute Spiekerkoetter, and René Santer. Evidence for a genotype–phenotype correlation in patients with pathogenic glut2 (slc2a2) variants. Genes, 12(11):1785, November 2021. URL: http://dx.doi.org/10.3390/genes12111785, doi:10.3390/genes12111785. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes12111785)